DNA methylation alterations in grade II- and anaplastic pleomorphic xanthoastrocytoma
Authors:
- Ramón MartínezRMRamón Martínez
- F Javier CarmonaFCF Javier Carmona
- Miguel VizosoMVMiguel Vizoso
- Veit RohdeVRVeit Rohde
- Matthias KirschMKMatthias Kirsch
- Gabriele SchackertGSGabriele Schackert
- Santiago RoperoSRSantiago Ropero
- Werner PaulusWPWerner Paulus
- Alonso BarrantesABAlonso Barrantes
- Antonio GomezAGAntonio Gomez
- Manel EstellerMEManel Esteller
Open Access
- 20 March 2014
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 14 (1) , 213
Abstract
Pleomorphic xanthoastrocytoma (PXA) is a rare WHO grade II tumor accounting for less than 1% of all astrocytomas. Malignant transformation into PXA with anaplastic features, is unusual and correlates with poorer outcome of the patients. Using a DNA methylation custom array, we have quantified the DNA methylation level on the promoter sequence of 807 cancer-related genes of WHO grade II (n = 11) and III PXA (n = 2) and compared to normal brain tissue (n = 10) and glioblastoma (n = 87) samples. DNA methylation levels were further confirmed on independent samples by pyrosequencing of the promoter sequences. Increasing DNA promoter hypermethylation events were observed in anaplastic PXA as compared with grade II samples. We further validated differential hypermethylation of CD81, HCK, HOXA5, ASCL2 and TES on anaplastic PXA and grade II tumors. Moreover, these epigenetic alterations overlap those described in glioblastoma patients, suggesting common mechanisms of tumorigenesis. Even taking into consideration the small size of our patient populations, our data strongly suggest that epigenome-wide profiling of PXA is a valuable tool to identify methylated genes, which may play a role in the malignant progression of PXA. These methylation alterations may provide useful biomarkers for decision-making in those patients with low-grade PXA displaying a high risk of malignant transformation.Keywords
This publication has 53 references indexed in Scilit:
- Xantoastrocitoma pleomórfico con extensión intraventricular y transformación anaplásica en paciente adulto: caso clínicoNeurocirugia, 2012
- MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastomaBMC Cancer, 2012
- Epigenetic disruption of cadherin‐11 in human cancer metastasisThe Journal of Pathology, 2012
- Methylation profiling identifies 2 groups of gliomas according to their tumorigenesisNeuro-Oncology, 2010
- Frequent hypermethylation and loss of heterozygosity of the testis derived transcript gene in ovarian cancerCancer Science, 2010
- Silencing of TESTIN by dense biallelic promoter methylation is the most common molecular event in childhood acute lymphoblastic leukaemiaMolecular Cancer, 2010
- Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19qOncogene, 2007
- The Epigenomics of CancerCell, 2007
- Distinct methylation profiles of glioma subtypesInternational Journal of Cancer, 2003
- Pleomorphic xanthoastrocytomaCancer, 1999